Correction to: Communications Biology https://doi.org/10.1038/s42003-021-02787-7, published online 19 November 2021.
An oversight was committed in neglecting to include several Malian co-authors who conducted the clinical study and provided samples for the study in the list of authors. This has now been corrected in the PDF and HTML versions of the Article.
Corrected list of authors and affiliations:
Jonathan P. Renn1, Justin Y.A. Doritchamou1, Bergeline C. Nguemwo Tentokam1, Robert D. Morrison1, Matthew V. Cowles1, Martin Burkhardt1, Rui Ma1, Almahamoudou Mahamar2, Oumar Attaher2, Bacary S. Diarra2, Moussa Traore2, Alassane Dicko2, Niraj H. Tolia1, Michal Fried1, Patrick E. Duffy1
1 Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
2 Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Renn, J.P., Doritchamou, J.Y.A., Tentokam, B.C.N. et al. Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity. Commun Biol 5, 404 (2022). https://doi.org/10.1038/s42003-022-03337-5
Published:
DOI: https://doi.org/10.1038/s42003-022-03337-5
